Table 3 Adverse neonatal outcomes among 831 women with pregnancy associated cancer (PAC) and 3324 matched cancer-free women. Lombardy, Italy. 2008–2017
Small for gestational age (Yes Vs No) | Apgar 5th Minute (Low Vs Normal) | Malformations (Yes Vs No) | Perinatal Mortality (Stillbirth Vs Livebirth) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
N (%) events | PR (95% CI) | aPR (95% CI) | N (%) events | PR (95% CI) | aPR (95% CI) | N (%) events | PR (95% CI) | aPR (95% CI) | N (%) events | PR (95% CI) | aPR (95% CI) | |
Cancer-free | 57 (7.7) | 1 a | 1 a | 9 (1.2) | 1 a | 1 a | 1 (0.1) | 1 a | 1 a | 4 (0.5) | 1 a | 1 a |
PAC during pregnancy | 10 (5.4) | 0.70 (0.37–1.35) | 0.71 (0.36–1.35) | 6 (3.2) | 2.67 (0.96–7.40) | 2.65 (0.96–7.33) | 0 (0.0) | Not estimable | 1 (0.5) | 1.00 (0.11–8.89) | 1.01 (0.11–8.29) | |
Cancer-free | 204 (7.9) | 1 a | 1 a | 41 (1.6) | 1 a | 1 a | 1 (0.0) | 1 a | 1 a | 6 (0.2) | 1 a | 1 a |
PAC post-pregnancy | 54 (8.4) | 1.06 (0.79–1.41) | 1.04 (0.78–1.39) | 8 (1.2) | 0.78 (0.37–1.66) | 0.66 (0.30–1.46) | 3 (0.5) | 12.00 (1.2–115.2) | 11.53 (1.2–111.5) | 2 (0.3) | 1.33 (0.27–6.59) | 0.59 (0.07–4.94) |